Dustin S. Sjuts

Companies

• Revance Therapeutics, Inc.President Nov 10, 2021 to Mar 19, 2024¹
• Revance Therapeutics, Inc.Chief Commercial Officer Dec 10, 2019 to Jul 2, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRevance Therapeutics, Inc.167,550 shares³Mar 18, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 18, 2024Sold 9,211 shares at $5.04 of Revance Therapeutics, Inc.³
• Mar 15, 2024Shares withheld for tax 2,967 shares at $5.31 of Revance Therapeutics, Inc.³
• Feb 29, 2024Granted 22,110 shares of Revance Therapeutics, Inc.⁴
• Dec 31, 2023Granted 264 shares at $7.47 of Revance Therapeutics, Inc.⁵
• Dec 15, 2023Shares withheld for tax 4,712 shares at $8.08 of Revance Therapeutics, Inc.⁶
• Aug 11, 2023Shares withheld for tax 8,901 shares at $18.91 of Revance Therapeutics, Inc.⁷
• Aug 11, 2023Granted 22,620 shares of Revance Therapeutics, Inc.⁷
• Jun 30, 2023Granted 1,000 shares at $15.61 of Revance Therapeutics, Inc.⁸
• Jun 9, 2023Sold 5,000 shares at $30.82 of Revance Therapeutics, Inc.⁹
• May 15, 2023Sold 21,015 shares at $34.55 of Revance Therapeutics, Inc.¹⁰
• Mar 15, 2023Shares withheld for tax 2,967 shares at $30.65 of Revance Therapeutics, Inc.¹¹
• Mar 9, 2023Sold 21,508 shares at $31.59 of Revance Therapeutics, Inc.¹²
• Feb 15, 2023Shares withheld for tax 2,766 shares at $33.21 of Revance Therapeutics, Inc.¹³
• Dec 31, 2022Granted 605 shares at $12.18 of Revance Therapeutics, Inc.¹⁴
• Dec 15, 2022Shares withheld for tax 2,916 shares at $21.50 of Revance Therapeutics, Inc.¹⁵
• Sep 22, 2022Granted 52,396 shares of Revance Therapeutics, Inc.¹²
• Jun 30, 2022Granted 1,000 shares at $11.75 of Revance Therapeutics, Inc.¹⁶
• Mar 15, 2022Shares withheld for tax 1,835 shares at $15.79 of Revance Therapeutics, Inc.¹⁷
• Feb 15, 2022Shares withheld for tax 295 shares at $13.35 of Revance Therapeutics, Inc.¹⁸
• Feb 15, 2022Shares withheld for tax 2,134 shares at $13.35 of Revance Therapeutics, Inc.¹⁸
• Feb 2, 2022Granted 52,395 shares of Revance Therapeutics, Inc.¹⁰
• Dec 15, 2021Shares withheld for tax 513 shares at $15.92 of Revance Therapeutics, Inc.¹⁹
• Nov 9, 2021Granted 35,920 shares of Revance Therapeutics, Inc.²⁰